We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Michael Wallace

Michael Bradley Wallace MD

Consultant, Division of Gastroenterology & Hepatology, Sheikh Shakbout Medical City, Abu Dhabi, United Arab Emirates, in partnership with Mayo Clinic; John C. Andersen Professor of Medicine, Mayo Clinic, Jacksonville, Florida

Dr. Wallace received his medical degree from Duke University School of Medicine in 1992. He completed a residency program in Internal Medicine in 1995 and a fellowship in Gastroenterology and Hepatology in 1998 at the Brigham and Women’s Hospital in Boston, Massachusetts. During that time, he also completed a Master’s in Public Health with a focus on clinical research at the Harvard School of Public Health.

Dr. Wallace completed an advanced endoscopy fellowship in Endoscopic Ultrasound (EUS) and Therapeutic Endoscopic Retrograde Cholangiopancreatography (ERCP) in 1999 at the Medical University of South Carolina. 

He remained on faculty at MUSC until 2003, when he joined the Mayo Clinic as associate professor and director of Gastroenterology Research.  He was promoted to professor in 2007.  Dr. Wallace served as Chair of the Research Committee for the American Society for Gastrointestinal Endoscopy from 2008-2011, Chair of Technology Assessment Committee 2013-14, and Editor in Chief of Gastrointestinal Endoscopy 2015-present. He has served as Chief of Gastroenterology and Hepatology at Mayo Clinic Florida and is currently the Chief of GI and Hepatology at Sheikh Shakhbout Medical City, Abu Dhabi.

Dr. Wallace’s research focuses on advanced endoscopic imaging technologies including endoscopic ultrasound, light scattering spectroscopy, autofluorescence imaging, narrow band imaging, confocal endomicroscopy and molecular imaging as they pertain to early neoplasia of the gastrointestinal tract.

Dr. Wallace was principal investigator in an NIDDK-funded trial of EUS Neurolysis in pancreas cancer.  He was also principal investigator in a National Cancer Institute-funded trial evaluating the role of EUS in lung cancer staging and currently holds NIH RO1 grants in Optical Coherence Tomography for esophageal cancer, and Artificial intelligence systems for early pancreas cancer detection.

Dr. Wallace has published more than 350 peer reviewed manuscripts and more than 300 abstracts, book chapters, review articles and editorials.  In addition, he has mentored more than 20 Advanced Endoscopy fellows from around the world, receiving mentor of the year awards from AGA and ASGE, and teacher and innovator of the year from Mayo Clinic.